Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Sofia Alexouda"'
Autor:
Kalliopi Liadaki, Efterpi Zafiriou, Themistoklis Giannoulis, Sofia Alexouda, Kleoniki Chaidaki, Polyxeni Gidarokosta, Angeliki-Viktoria Roussaki-Schulze, Sotirios G. Tsiogkas, Athina Daponte, Zissis Mamuris, Dimitrios P. Bogdanos, Nicholas K. Moschonas, Theologia Sarafidou
Publikováno v:
Genes, Vol 15, Iss 3, p 369 (2024)
Moderate-to-severe psoriasis (Ps) treatment includes systemic drugs and biological agents. Apremilast, a small molecule primarily metabolized by cytochrome CYP3A4, modulates the immune system by specifically inhibiting phosphodiesterase type 4 (PDE4)
Externí odkaz:
https://doaj.org/article/3991ff218e754f98836807688f8ebf35
Autor:
Dimitrios Ntelios, Soultana Meditskou, Georgios Efthimiadis, Antonios Pitsis, Thomas Zegkos, Despoina Parcharidou, Paschalis Theotokis, Sofia Alexouda, Haralampos Karvounis, Georgios Tzimagiorgis
Publikováno v:
Pathology international. 72(5)
Autor:
Antigoni Malousi, Georgios Tzimagiorgis, Sofia Alexouda, Georgios K. Efthimiadis, Dimitrios Ntelios, Elisavet Georgiou
Publikováno v:
Heart failure reviewsReferences. 27(1)
MicroRNAs (miRNAs) are small noncoding RNA molecules that act as major regulators of gene expression at the post-transcriptional level. As the potential applications of miRNAs in the diagnosis and treatment of human diseases have become more evident,